| Date | Time | Source | Headline | Symbol | Company |
| 07/18/2023 | 12:15AM | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 07/11/2023 | 12:09PM | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 07/11/2023 | 12:05PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 07/11/2023 | 12:00PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 07/11/2023 | 11:56AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 07/11/2023 | 11:55AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 07/11/2023 | 11:54AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 07/11/2023 | 11:52AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 07/11/2023 | 11:51AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 07/11/2023 | 11:51AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 07/11/2023 | 11:50AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 07/11/2023 | 11:50AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 07/11/2023 | 11:48AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 07/11/2023 | 11:43AM | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 07/11/2023 | 9:37AM | Edgar (US Regulatory) | Form 8-K - Current report | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 06/30/2023 | 5:08PM | Edgar (US Regulatory) | Form 8-K - Current report | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 05/01/2023 | 4:17PM | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 04/14/2023 | 8:01AM | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 04/06/2023 | 4:17PM | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 03/02/2023 | 8:02AM | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 02/16/2023 | 4:32PM | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 02/13/2023 | 6:04AM | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 02/10/2023 | 9:49AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 01/12/2023 | 6:16AM | Edgar (US Regulatory) | Current Report Filing (8-k) | USOTC:CLVSQ | Clovis Oncology Inc (PK) |
| 12/29/2022 | 9:36AM | Edgar (US Regulatory) | Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse) | USOTC:CLVSQ | Clovis Oncology Inc (PK) |